American Society of Clinical Oncology

Study suggests patients with lung cancer who carry specific HER2 mutations may benefit from certain anti-HER2 treatments

New results from a retrospective study conducted in Europe suggest that anti-HER2 treatments, like the widely used breast cancer agent trastuzumab (Herceptin), have anti-cancer effects in a small subset of patients with advanced ...

Cancer Apr 22, 2013 | not rated yet | 0